Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28222
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYip, Raymond K H-
dc.contributor.authorRimes, Joel S-
dc.contributor.authorCapaldo, Bianca D-
dc.contributor.authorVaillant, François-
dc.contributor.authorMouchemore, Kellie A-
dc.contributor.authorPal, Bhupinder-
dc.contributor.authorChen, Yunshun-
dc.contributor.authorSurgenor, Elliot-
dc.contributor.authorMurphy, Andrew J-
dc.contributor.authorAnderson, Robin L-
dc.contributor.authorSmyth, Gordon K-
dc.contributor.authorLindeman, Geoffrey J-
dc.contributor.authorHawkins, Edwin D-
dc.contributor.authorVisvader, Jane E-
dc.date2021-11-26-
dc.date.accessioned2021-12-07T02:50:54Z-
dc.date.available2021-12-07T02:50:54Z-
dc.date.issued2021-11-26-
dc.identifier.citationNature Communications 2021; 12(1): 6920en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28222-
dc.description.abstractBone marrow is a preferred metastatic site for multiple solid tumours and is associated with poor prognosis and significant morbidity. Accumulating evidence indicates that cancer cells colonise specialised niches within the bone marrow to support their long-term propagation, but the precise location and mechanisms that mediate niche interactions are unknown. Using breast cancer as a model of solid tumour metastasis to the bone marrow, we applied large-scale quantitative three-dimensional imaging to characterise temporal changes in the bone marrow microenvironment during disease progression. We show that mouse mammary tumour cells preferentially home to a pre-existing metaphyseal domain enriched for type H vessels. Metastatic lesion outgrowth rapidly remodelled the local vasculature through extensive sprouting to establish a tumour-supportive microenvironment. The evolution of this tumour microenvironment reflects direct remodelling of the vascular endothelium through tumour-derived granulocyte-colony stimulating factor (G-CSF) in a hematopoietic cell-independent manner. Therapeutic targeting of the metastatic niche by blocking G-CSF receptor inhibited pathological blood vessel remodelling and reduced bone metastasis burden. These findings elucidate a mechanism of 'host' microenvironment hijacking by mammary tumour cells to subvert the local microvasculature to form a specialised, pro-tumorigenic niche.en
dc.language.isoeng
dc.titleMammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis.en
dc.typeJournal Articleen
dc.identifier.journaltitleNature Communicationsen
dc.identifier.affiliationInflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australiaen
dc.identifier.affiliationDepartment of Immunology, Monash University, Melbourne, VIC, Australiaen
dc.identifier.affiliationDivision of Immunometabolism, Baker Heart & Diabetes Institute, Melbourne, VIC, Australiaen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationBioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australiaen
dc.identifier.affiliationSchool of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationACRF Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australiaen
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.affiliationDepartment of Medical Oncology and Parkville Familial Cancer Centre, The Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, VIC, 3050, Australiaen
dc.identifier.affiliationDepartment of Medical Biology, The University of Melbourne, Parkville, VIC, 3010, Australiaen
dc.identifier.doi10.1038/s41467-021-26556-6en
dc.type.contentTexten
dc.identifier.orcid0000-0003-2698-7686en
dc.identifier.orcid0000-0001-6488-2784en
dc.identifier.orcid0000-0003-3229-3760en
dc.identifier.orcid0000-0002-3684-4331en
dc.identifier.orcid0000-0003-4911-5653en
dc.identifier.orcid0000-0001-7039-7777en
dc.identifier.orcid0000-0001-9221-2892en
dc.identifier.orcid0000-0001-9386-2416en
dc.identifier.orcid0000-0002-3686-8261en
dc.identifier.orcid0000-0001-9173-6977en
dc.identifier.pubmedid34836954
local.name.researcherAnderson, Robin L
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Jan 13, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.